Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

ENVISION

Financiado

Novel mechanisms of early defense against virus infections

Virus-induced type I interferons (IFN) have classically been considered to constitute the first line of defense against virus infections However, recent work by us and others has identified early antiviral actions that occur indep... ver más

30/11/2024

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

AARHUS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-06-22

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2017-ADG: ERC Advanced Grant

I+D

Cerrada hace 7 años

0% 100%

2 Participantes

2.48M€ | Lider

MULTIMOS

244.44K€ | Participante

Proyectos interesantes

PID2021-123810OB-I00 PAPEL DE GENES ACTIVADOS POR INTERFERON EN LA INDUCCION DE R... 230K€ Cerrado

RYC-2014-15516 Immunology of lentiviral infections 309K€ Cerrado

CNS2023-143738 Biología molecular y celular 200K€ Cerrado

RTI2018-094213-A-I00 PAPEL DE PROTEINAS DEL VIRUS DE LA GRIPE EN LA INDUCCION DE... 121K€ Cerrado

RYC2021-032674-I Infection, immunity and antiviral mechanisms in pandemic vir... 236K€ Cerrado

SAF2014-54623-R PEQUEÑOS CAMBIOS, ENORMES CONSECUENCIAS: PAPEL DE LA MODICAC... 169K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 77 meses Fecha Inicio: 2018-06-22
Fecha Fin: 2024-11-30

Líder del proyecto

AARHUS UNIVERSITET

TRL 4-5

Presupuesto del proyecto 2M€

Descripción del proyecto Virus-induced type I interferons (IFN) have classically been considered to constitute the first line of defense against virus infections However, recent work by us and others has identified early antiviral actions that occur independently of inducible type I and III IFN expression and sometimes even prior to IFN action (e.g. Iversen,...., Paludan. Nature Immunology, 2016; Paludan. Trends in Immunology, 2016). These discoveries challenge the current thinking in the field that IFNs constitute the first line of defense. Hence, there is an urgent need for more detailed understanding of the immediate antiviral defense mechanisms. Most importantly, we remain to identify key players in IFN-independent antiviral responses, we completely lack insight into the mechanisms that govern these responses, and we also lack information on the importance of this layer of defense in mice and humans. In accord with this, my proposal follows four aims: (i) Identification of mechanisms of virus detection at epithelial surfaces, (ii) elucidation of the role of tonic IFN signaling in antiviral defense, (iii) identification and characterization of novel restriction factors, and (iv) deciphering the mechanisms that govern induction of the first wave of IFNs at epithelial surfaces. In addition, I will also explore the interactions between the early antiviral actions. To achieve the goals, I will combine unbiased genome-wide screens with hypothesis-driven approaches, and will integrate molecular biology/genetics/biochemistry with advanced cell culture systems, animal science and analysis of patient material. Strong preliminary data have been generated for all four aims, and world-leading collaborations are in place, hence minimizing the risks, and allowing fast progress. Our findings will (i) change the thinking in innate immunology by uncovering a novel layer of antiviral defense and (ii) provide new avenues for therapeutic modulation of immune responses.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores